These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33000553)

  • 1. Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience.
    Bennett I; Tourani S; Cockburn L; Reasbeck J; Grobbelaar N; Dann S; Patrikios P; Brazier J
    ANZ J Surg; 2021 Apr; 91(4):685-690. PubMed ID: 33000553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of multimodality breast screening for women at increased risk of familial breast cancer.
    Bennett IC; Muller J; Cockburn L; Joshua H; Thorley G; Baker C; Wood N; Brazier J; Jones M; Dunn N; Gattas M
    World J Surg; 2010 May; 34(5):979-86. PubMed ID: 20108093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
    Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
    Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
    Bick U; Engel C; Krug B; Heindel W; Fallenberg EM; Rhiem K; Maintz D; Golatta M; Speiser D; Rjosk-Dendorfer D; Lämmer-Skarke I; Dietzel F; Schäfer KWF; Leinert E; Weigel S; Sauer S; Pertschy S; Hofmockel T; Hagert-Winkler A; Kast K; Quante A; Meindl A; Kiechle M; Loeffler M; Schmutzler RK;
    Breast Cancer Res Treat; 2019 May; 175(1):217-228. PubMed ID: 30725383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial outcomes and health service use after notifying women participating in population breast screening when they have dense breasts: a BreastScreen Queensland randomised controlled trial.
    Nickel B; Ormiston-Smith N; Hammerton L; Cvejic E; Vardon P; Mcinally Z; Legerton P; Baker K; Isautier J; Larsen E; Giles M; Brennan ME; McCaffery KJ; Houssami N
    Med J Aust; 2023 Nov; 219(9):423-428. PubMed ID: 37751916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial.
    Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA
    Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
    Dunn N; Youl P; Moore J; Harden H; Walpole E; Evans E; Taylor K; Philpot S; Furnival C
    J Med Screen; 2021 Jun; 28(2):193-199. PubMed ID: 32842857
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.